ophthalmologytimes12h
Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...
Stem cell shots: Unveiling a safer way to treat inflammatory eye diseases
Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...